نتائج البحث - "Fredrik Thoren"

1

Long‐term (52‐week) efficacy and safety of dapagliflozin as an adjunct to insulin therapy in Japanese patients with type 1 diabetes: Subgroup analysis of the DEPICT ‐2 study

المؤلفون: Hiroki Ikeda, Eiichi Araki, Nayyar Iqbal, Niki Arya, Hajime Maeda, Michiko Asano, Fredrik Thoren, Toshihiko Shiraiwa, Chantal Mathieu

المصدر: Diabetes, Obesity & Metabolism

مصطلحات موضوعية: safety, Blood Glucose, medicine.medical_specialty, Diabetic ketoacidosis, type 1 diabetes, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Population, long‐term efficacy, 030209 endocrinology & metabolism, Subgroup analysis, 030204 cardiovascular system & hematology, Hypoglycemia, Placebo, Gastroenterology, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Endocrinology, Double-Blind Method, Glucosides, Japan, Internal medicine, Japanese subpopulation, Internal Medicine, medicine, Humans, Hypoglycemic Agents, Insulin, Single-Blind Method, Benzhydryl Compounds, Dapagliflozin, education, Glycated Hemoglobin, Type 1 diabetes, education.field_of_study, business.industry, Blood Glucose Self-Monitoring, Original Articles, dapagliflozin, medicine.disease, Diabetes Mellitus, Type 1, Treatment Outcome, chemistry, Original Article, Drug Therapy, Combination, business, hypoglycaemia

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecdd7c07f1a9ecbc384927fadd193496Test
https://doi.org/10.1111/dom.14362Test

2

Long‐term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: pooled 52‐week outcomes from the DEPICT ‐1 and ‐2 studies

المؤلفون: Paresh Dandona, Depict Investigators, Depict, Niki Arya, Simon Heller, Paolo Di Bartolo, Lars Hansen, Richard M. Bergenstal, Eiichi Araki, Moshe Phillip, John Xu, Markus F. Scheerer, Nayyar Iqbal, Chantal Mathieu, Marcus Lind, Fredrik Thoren

المصدر: Diabetes, Obesity & Metabolism

مصطلحات موضوعية: Adult, medicine.medical_specialty, Diabetic ketoacidosis, Endocrinology, Diabetes and Metabolism, 030209 endocrinology & metabolism, 030204 cardiovascular system & hematology, Body weight, Placebo, 03 medical and health sciences, chemistry.chemical_compound, dapagliflozin, DEPICT, DKA, insulin adjunct, long‐term data, severe hypoglycaemia, SGLT‐2 inhibitor, T1D, 0302 clinical medicine, Endocrinology, Double-Blind Method, Glucosides, Internal medicine, Internal Medicine, medicine, Humans, Hypoglycemic Agents, In patient, Benzhydryl Compounds, Dapagliflozin, Glycated Hemoglobin, Type 1 diabetes, business.industry, Original Articles, medicine.disease, Diabetes Mellitus, Type 1, Treatment Outcome, Pooled analysis, chemistry, Baseline characteristics, Drug Therapy, Combination, Original Article, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7eeabb346397e1e4e7778837ac220da0Test
https://doi.org/10.1111/dom.14248Test

3

Effect of dapagliflozin as an adjunct to insulin over 52 weeks in individuals with type 1 diabetes: post-hoc renal analysis of the DEPICT randomised controlled trials

المؤلفون: Johan Jendle, Paresh Dandona, John Xu, Nayyar Iqbal, Enrico Repetto, Markus F. Scheerer, Steven V. Edelman, Per-Henrik Groop, Fredrik Thoren, Moshe Phillip, Pieter Gillard, Chantal Mathieu

المساهمون: Pathology/molecular and cellular medicine, Diabetes Pathology & Therapy, Diabetes Clinic

المصدر: The Lancet Diabetes & Endocrinology. 8:845-854

مصطلحات موضوعية: Blood Glucose, Male, Endocrinology, Diabetes and Metabolism, Biomarkers/analysis, Glycated Hemoglobin A/analysis, chemistry.chemical_compound, 0302 clinical medicine, Endocrinology, Glucosides, Insulin, 030212 general & internal medicine, Dapagliflozin, Prospective cohort study, education.field_of_study, Middle Aged, Prognosis, Diabetic Ketoacidosis/prevention & control, Insulin/therapeutic use, Creatinine, Drug Therapy, Combination, Female, medicine.symptom, Glomerular Filtration Rate, Adult, medicine.medical_specialty, Adolescent, Diabetic ketoacidosis, Albuminuria/prevention & control, Population, Diabetes Mellitus, Type 1/drug therapy, Hypoglycemic Agents/therapeutic use, 030209 endocrinology & metabolism, Placebo, Diabetic Ketoacidosis, Young Adult, 03 medical and health sciences, Double-Blind Method, Benzhydryl Compounds/therapeutic use, Internal medicine, Internal Medicine, medicine, Albuminuria, Humans, Hypoglycemic Agents, Benzhydryl Compounds, Adverse effect, education, Sodium-Glucose Transporter 2 Inhibitors, Aged, Glycated Hemoglobin, Type 1 diabetes, business.industry, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Blood Glucose/analysis, Creatinine/blood, medicine.disease, Glucosides/therapeutic use, Diabetes Mellitus, Type 1, chemistry, business, Biomarkers, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00f7846f46b1b29ed6f481ec3393eac5Test
https://doi.org/10.1016/s2213-8587Test(20)30280-1

4

Efficacy and safety of dapagliflozin in Japanese patients with inadequately controlled type 1 diabetes (DEPICT‐5): 52‐week results from a randomized, open‐label, phase III clinical trial

المؤلفون: Hiroshi Ohashi, Eiichi Araki, Hirotaka Watada, Anna Maria Langkilde, Osamu Tomonaga, Yasuko Uchigata, Michiko Asano, Fredrik Thoren, Toshitaka Yajima, Hyosung Kim, Hitomi Fujii, Tadashi Okabe

المصدر: Diabetes, Obesity & Metabolism

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2310911b14b196e9e322bd4b599cd7a1Test
https://doi.org/10.1111/dom.13922Test

5

Pharmacokinetics and pharmacodynamics of dapagliflozin in combination with insulin in Japanese patients with type 1 diabetes

المؤلفون: Hyosung Kim, Shinya Ueda, Michiko Asano, Toshitaka Yajima, David W. Boulton, Weifeng Tang, Fredrik Thoren, Eiichi Araki, Masanari Shiramoto, Hirotaka Watada

المصدر: Diabetes, Obesity & Metabolism

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Diabetic ketoacidosis, type 1 diabetes, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Urology, 030209 endocrinology & metabolism, 030204 cardiovascular system & hematology, Placebo, 03 medical and health sciences, chemistry.chemical_compound, Glucuronides, 0302 clinical medicine, Endocrinology, Japan, Glucosides, Pharmacokinetics, Glycosuria, pharmacodynamics, Internal Medicine, medicine, Humans, Hypoglycemic Agents, Insulin, Benzhydryl Compounds, Dapagliflozin, Adverse effect, Sodium-Glucose Transporter 2 Inhibitors, Type 1 diabetes, Dose-Response Relationship, Drug, business.industry, Original Articles, dapagliflozin, Middle Aged, medicine.disease, Diabetes Mellitus, Type 1, chemistry, Pharmacodynamics, Original Article, Drug Therapy, Combination, Female, business, pharmacokinetics

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ba57fbacce583b116c84838b690d928Test
https://doi.org/10.1111/dom.13593Test

6

Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (the DEPICT-2 study): 52-week results from a randomized controlled trial

المؤلفون: Eiichi Araki, Markus F. Scheerer, Fredrik Thoren, Gottfried Rudofsky, Paresh Dandona, Nayyar Iqbal, Niki Arya, Chantal Mathieu, Marcus Lind, Moshe Phillip

المصدر: Diabetes, Obesity & Metabolism

مصطلحات موضوعية: Adult, medicine.medical_specialty, Diabetic ketoacidosis, type 1 diabetes, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, 030209 endocrinology & metabolism, 030204 cardiovascular system & hematology, Placebo, law.invention, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Endocrinology, Glucosides, Randomized controlled trial, law, Internal medicine, Internal Medicine, medicine, Humans, In patient, Benzhydryl Compounds, Dapagliflozin, Adverse effect, Glycated Hemoglobin, Type 1 diabetes, business.industry, Insulin, SGLT2 inhibitor, Original Articles, dapagliflozin, medicine.disease, DEPICT-2, Diabetes Mellitus, Type 1, chemistry, Drug Therapy, Combination, Original Article, dapagliflozin, DEPICT‐2, SGLT2 inhibitor, type 1 diabetes, business

وصف الملف: Print-Electronic

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bebf6d5b1fe63809f16f7692cedd9aa7Test
https://lirias.kuleuven.be/handle/123456789/653784Test

7

Benefit/risk profile of dapagliflozin 5 mg in the DEPICT-1 and -2 trials in individuals with type 1 diabetes and body mass index ≥27 kg/m

المؤلفون: Chantal, Mathieu, Paresh, Dandona, Andreas L, Birkenfeld, Troels Krarup, Hansen, Nayyar, Iqbal, John, Xu, Enrico, Repetto, Markus Florian, Scheerer, Fredrik, Thoren, Moshe, Phillip

المصدر: Diabetes, Obesity & Metabolism

مصطلحات موضوعية: HbA1c, type 1 diabetes, DEPICT, Original Articles, dapagliflozin, Body Mass Index, benefit/risk, BMI, body weight, Diabetes Mellitus, Type 1, Glucosides, DKA, Humans, Hypoglycemic Agents, Original Article, T1D, Benzhydryl Compounds

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid________::bd762df03eab006a3cc9da231ba0ad84Test
https://pubmed.ncbi.nlm.nih.gov/32691513Test

8

Glucose Variables in Type 1 Diabetes Studies With Dapagliflozin: Pooled Analysis of Continuous Glucose Monitoring Data From DEPICT-1 and -2

المؤلفون: Lars Hansen, Tal Oron, Anna Maria Langkilde, Chantal Mathieu, Marcus Lind, John Xu, Fredrik Thoren, Moshe Phillip, Paresh Dandona

المصدر: Diabetes care. 42(6)

مصطلحات موضوعية: Adult, Blood Glucose, Male, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Urology, 030209 endocrinology & metabolism, Hypoglycemia, Placebo, 03 medical and health sciences, chemistry.chemical_compound, Young Adult, 0302 clinical medicine, Double-Blind Method, Glucosides, Diabetes mellitus, Internal Medicine, medicine, Humans, Hypoglycemic Agents, Insulin, Multicenter Studies as Topic, 030212 general & internal medicine, Longitudinal Studies, Dapagliflozin, Benzhydryl Compounds, Glycemic, Aged, Randomized Controlled Trials as Topic, Retrospective Studies, Advanced and Specialized Nursing, Glycated Hemoglobin, Type 1 diabetes, business.industry, Blood Glucose Self-Monitoring, Middle Aged, medicine.disease, Postprandial, Diabetes Mellitus, Type 1, Treatment Outcome, chemistry, Clinical Trials, Phase III as Topic, Drug Therapy, Combination, Female, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab7f5f435938756672c8e60cab2657caTest
https://pubmed.ncbi.nlm.nih.gov/30967434Test

9

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study

المؤلفون: Diethelm Tschöpe, Lars Hansen, John Xu, Moshe Phillip, Anna Maria Langkilde, Depict Investigators, Chantal Mathieu, Paresh Dandona, Fredrik Thoren

المصدر: Diabetes care. 41(12)

مصطلحات موضوعية: Adult, Blood Glucose, Male, medicine.medical_specialty, Diabetic ketoacidosis, Endocrinology, Diabetes and Metabolism, 030209 endocrinology & metabolism, Hypoglycemia, Placebo, Gastroenterology, Placebos, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Double-Blind Method, Glucosides, Weight loss, Internal medicine, Diabetes mellitus, Weight Loss, Internal Medicine, medicine, Humans, Hypoglycemic Agents, Insulin, 030212 general & internal medicine, Dapagliflozin, Benzhydryl Compounds, Glycemic, Advanced and Specialized Nursing, Glycated Hemoglobin, Type 1 diabetes, business.industry, medicine.disease, Diabetes Mellitus, Type 1, Treatment Outcome, chemistry, Drug Therapy, Combination, Female, medicine.symptom, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bb04b919124068d49cd983781a31022Test
https://pubmed.ncbi.nlm.nih.gov/30459245Test

تنقيح النتائج